comparemela.com
Home
Live Updates
Molecular Templates : 10-K/A Filing FY 2022 : comparemela.com
Molecular Templates : 10-K/A Filing FY 2022
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K/A
... | April 28, 2023
Related Keywords
France ,
Romania ,
Delaware ,
United States ,
San Francisco ,
California ,
Bucharest ,
Bucuresti ,
Texas ,
Menlo Park ,
Washington ,
Stanford University ,
Paris ,
France General ,
Colorado ,
French ,
American ,
Patrickg Enright ,
Kevinm Lalande ,
Davidr Hoffmann ,
Jasons Kim ,
Kevin Lalande ,
Markn Lampert ,
Jonathan Lanfear ,
Corsee Sanders ,
Eli Lilly ,
Harolde Barry Selick ,
David Hirsch ,
Joe Cunningham ,
Zimmer Biomet ,
Erice Poma ,
Gabriela Gruia ,
Harolde Selick ,
Scott Morenstein ,
Rogerj Waltzman ,
Lumos Pharma ,
Clinical Development ,
Company On ,
Permissible Services Of Independent Public Accountant ,
University Of Colorado ,
Biotechnology Value Fund ,
Name Of Each Exchange ,
Napo Pharmaceuticals Inc ,
Harvard Medical School ,
Wharton School ,
Company Certificate Of Designation Preferences ,
Exchange Act Person ,
Jaguar Health Inc ,
Principal At Lanfear Advisors ,
Juno Therapeutic Development Organization ,
Partners Os Ltd ,
Trading Fund ,
Artham Therapeutics Inc ,
Amunixpharmaceuticals Inc ,
Ichnos Sciences ,
Hoffmann Associates ,
Molecular Templates Inc ,
Wharton Doctoral Program ,
Regulatory Sciences ,
Holding Corporation ,
Poseida Therapeutics Inc ,
Compensation Committee ,
Johns Hopkins University Our Board ,
Collegium Pharmaceutical Inc ,
Company Board ,
Inspirna Inc ,
Hibercell Inc ,
Corporate Governance Committee ,
Astellas Pharma Us Inc ,
Procedures For Related Party Transactions ,
Brigham Young University ,
Wesleyan University ,
Theranostics Inc ,
Takeda Pharmaceuticals ,
University Of California ,
Business Administration ,
Development Operations ,
Rgenix Inc ,
Securities Exchange ,
Tessa Therapeutics Ltd ,
Nasdaq ,
University Of Pennsylvania ,
Beigene Ltd ,
Legend Biotech Corporation ,
Imclone Systems Inc ,
Novartis Pharmaceuticals Corporation ,
Damon Runyon Walter Winchell Cancer Fund ,
Rd Business Development ,
Brown University School Of Medicine ,
Member Of The Audit Committee ,
Audit Committee Our ,
Rapid Micro Biosystems Inc ,
Harvard Business School ,
American Cancer Society Senior ,
Exchange Act Person The Subject ,
Ultragenyx Pharmaceuticals Inc ,
Annex Services ,
Audit Committee ,
Board Or Committee ,
Stage Portfolio Committee ,
Health Venturesi Annex Fund ,
University Of Michigan Ann Arbor ,
Regulation Sk Our Audit Committee ,
Longitude Capital Partners ,
University Of Pennsylvania Our Board ,
Exchange Commission ,
Office Of The Celgene ,
Bucharest Medical School ,
Aquinnah Pharmaceuticals ,
Massachusetts Institute Of Technology ,
Brown University ,
Columbia Business School ,
University Of The Philippines ,
Rene Huguenin Curie Institute Cancer Center ,
Amunix Pharmaceuticals ,
Auditor Firm ,
Principal Of Gabriela Gruia Consulting ,
Health Ventures ,
Board Of Trustees ,
Business Development ,
Global Development Group Of Bristol Myers Squibb ,
Member Of The Compensation Committee ,
Audit Committee Pre ,
Pharmaceuticals Inc ,
University Of North Carolina At Chapel Hill ,
Celgene Organization ,
York University Our Board ,
Your Audit Committee ,
Tricida Inc ,
Management Services ,
Rene Descartes University ,
Ernst Young ,
Washington University St ,
Mark One ,
Zip Code ,
Exchange Act ,
Each Exchange ,
Value Per Share ,
Securities Exchange Act ,
Interactive Data File ,
Regulations T ,
Sarbanes Oxley Act ,
Nasdaq Global Select Market ,
Common Stock ,
Annual Report ,
Molecular Templates ,
Private Molecular ,
Private Securities Litigation Reform Act ,
Shiga Like Toxin ,
Executive Officer ,
Chief Scientific Officer ,
Chief Executive Officer ,
Vice President ,
North Carolina ,
Chapel Hill ,
New York University Our Board ,
Vice Chancellor ,
Pre Merger Threshold ,
Catalyst Biosciences ,
Protagonist Therapeutics ,
Damon Runyon Walter Winchell Cancer Fund Fellow ,
American Cancer Society Senior Fellow ,
Chief Executive ,
Gabriela Gruia Consulting ,
Chief Development Officer ,
Clinical Operations ,
Clinical Pharmacology ,
From August ,
Senior Vice President ,
Global Head ,
Regulatory Affairs ,
Novartis Oncology ,
Tessa Therapeutics ,
Breast Pathology ,
Curie Institute Cancer Center ,
Venture Partner ,
Longitude Capital ,
Poseida Therapeutics ,
Rapid Micro Biosystems ,
Collegium Pharmaceutical ,
Massachusetts Institute ,
Managing Member ,
Computer Engineering ,
Highest Distinction ,
Artificial Intelligence ,
Lanfear Advisors ,
Chief Operating Officer ,
Chemical Engineering ,
Ann Arbor ,
Washington University ,
Strategic Advisor ,
Global Development Group ,
Bristol Myers ,
Celgene Chief Medical Officer ,
Chief Medical Officer ,
Juno Therapeutics Executive Committee ,
Roche Late Stage Portfolio Committee ,
Roche Late Stage Clinical Operations ,
Fred Hutchinson Cancer Research ,
Ultragenyx Pharmaceuticals ,
Legend Biotech ,
Magna Cum Laude ,
Pennsylvania Our Board ,
Committee Our Audit ,
Insider Trading Policy ,
Business Conduct ,
Current Report ,
Interim Chief Financial Officer ,
Chief Financial Officer ,
Astellas Pharma ,
Imclone Systems ,
Jaguar Health ,
Napo Pharmaceuticals ,
From January ,
Executive Director ,
Brown University School ,
Principal Position ,
Financial Statements ,
Summary Compensation Table ,
Equity Awards ,
Summary Compensation ,
Good Reason ,
Cure Period ,
Incentive Plan ,
Subject Person ,
Incumbent Board ,
Per Year ,
Preferred Stock ,
Percent Stockholders ,
Hill Road ,
Executive Officers ,
Longitude Venture Partners ,
Longitude Venture ,
Convertible Preferred Stock ,
Biotechnology Value Trading Fund ,
Trading Funds ,
Partners Managed ,
Partners Managed Accounts ,
Convertible Preferred ,
Restated Equity Incentive Plan ,
Stock Purchase ,
Related Person Transactions ,
Restated Certificate ,
Restated Bylaws ,
Related Party Transactions ,
Regulations K ,
Nasdaq Listing Rules ,
Under Rule ,
Nasdaq Listing ,
Audit Committee Pre Approval ,
Permissible Non Audit Services ,
Independent Public Accountant ,
Consolidated Financial Statements ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
United ,
Securities ,
End ,
Exchange ,
Orm Mtem Us6085501095 ,
comparemela.com © 2020. All Rights Reserved.